🇺🇸 FDA
Pipeline program

Buccal Buprenorphine 300 mcg

222204

Approved small_molecule active

Quick answer

Buccal Buprenorphine 300 mcg for Analgesia is a Approved program (small_molecule) at BRIGHT MINDS BIOSCIENCES INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
BRIGHT MINDS BIOSCIENCES INC.
Indication
Analgesia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials